loading

Akero Therapeutics Inc 주식(AKRO)의 최신 뉴스

pulisher
Jun 18, 2025

Akero Therapeutics (NASDAQ:AKRO) Stock Price Down 3.3%Time to Sell? - MarketBeat

Jun 18, 2025
pulisher
Jun 15, 2025

Don't Ignore The Insider Selling In Akero Therapeutics - simplywall.st

Jun 15, 2025
pulisher
Jun 15, 2025

Insider Selling: Akero Therapeutics, Inc. (NASDAQ:AKRO) Insider Sells 2,803 Shares of Stock - MarketBeat

Jun 15, 2025
pulisher
Jun 15, 2025

Insider Selling: Akero Therapeutics, Inc. (NASDAQ:AKRO) VP Sells 919 Shares of Stock - MarketBeat

Jun 15, 2025
pulisher
Jun 14, 2025

Insider Selling: Akero Therapeutics, Inc. (NASDAQ:AKRO) COO Sells 2,493 Shares of Stock - MarketBeat

Jun 14, 2025
pulisher
Jun 14, 2025

Akero Therapeutics, Inc. (NASDAQ:AKRO) Insider Sells $127,332.00 in Stock - MarketBeat

Jun 14, 2025
pulisher
Jun 14, 2025

Akero Therapeutics, Inc. (NASDAQ:AKRO) CFO Sells $151,387.96 in Stock - MarketBeat

Jun 14, 2025
pulisher
Jun 14, 2025

Rhumbline Advisers Purchases 5,001 Shares of Akero Therapeutics, Inc. (NASDAQ:AKRO) - MarketBeat

Jun 14, 2025
pulisher
Jun 14, 2025

Millennium Management LLC Lowers Stock Holdings in Akero Therapeutics, Inc. (NASDAQ:AKRO) - MarketBeat

Jun 14, 2025
pulisher
Jun 14, 2025

Akero Therapeutics (AKRO) Emerges as Attractive Acquisition Targ - GuruFocus

Jun 14, 2025
pulisher
Jun 14, 2025

Akero Therapeutics, Inc. (NASDAQ:AKRO) Shares Bought by SG Americas Securities LLC - MarketBeat

Jun 14, 2025
pulisher
Jun 13, 2025

Jefferies Names Akero Therapeutics, Scholar Rock As Biotech Companies With Takeover Potential, But Retail Isn’t Pleased By Stocktwits - Investing.com India

Jun 13, 2025
pulisher
Jun 13, 2025

Jefferies Names Akero Therapeutics, Scholar Rock As Biotech Companies With Takeover Potential, But Retail Isn’t Pleased - MSN

Jun 13, 2025
pulisher
Jun 13, 2025

Akero Therapeutics, Inc. (NASDAQ:AKRO) Insider Sells $668,625.00 in Stock - MarketBeat

Jun 13, 2025
pulisher
Jun 13, 2025

Investors Buy Large Volume of Call Options on Akero Therapeutics (NASDAQ:AKRO) - MarketBeat

Jun 13, 2025
pulisher
Jun 12, 2025

Akero Therapeutics, Inc. (NASDAQ:AKRO) Insider Sells $1,376,000.00 in Stock - MarketBeat

Jun 12, 2025
pulisher
Jun 12, 2025

Insider Selling: Akero Therapeutics, Inc. (NASDAQ:AKRO) CEO Sells 37,837 Shares of Stock - MarketBeat

Jun 12, 2025
pulisher
Jun 12, 2025

Akero Therapeutics Executives Sell Shares to Cover Tax Obligations - TradingView

Jun 12, 2025
pulisher
Jun 12, 2025

(AKRO) Technical Data - news.stocktradersdaily.com

Jun 12, 2025
pulisher
Jun 12, 2025

Akero Therapeutics, Inc. (NASDAQ:AKRO) Shares Purchased by UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC - MarketBeat

Jun 12, 2025
pulisher
Jun 10, 2025

Transcript : Akero Therapeutics, Inc. Presents at Goldman Sachs 46th Annual Global Healthcare Conference 2025, Jun-10-2025 02 - MarketScreener

Jun 10, 2025
pulisher
Jun 10, 2025

Day 8 of Gains Streak for Akero Therapeutics Stock with 21% Return (vs. 97% YTD) [6/9/2025] - Trefis

Jun 10, 2025
pulisher
Jun 09, 2025

MASH Market Size in the 7MM was ~USD 1.8 billion in 2023, is projected to grow at a CAGR of 24%, estimates DelveInsight - The Globe and Mail

Jun 09, 2025
pulisher
Jun 09, 2025

Akero Therapeutics' Chief Scientific Officer Sells Shares - TradingView

Jun 09, 2025
pulisher
Jun 09, 2025

Rumor Fuels Akero Therapeutics (AKRO) Stock Movement | AKRO Stoc - GuruFocus

Jun 09, 2025
pulisher
Jun 09, 2025

Rumor Fuels Akero Therapeutics (AKRO) Stock Movement | AKRO Stock News - GuruFocus

Jun 09, 2025
pulisher
Jun 08, 2025

Ameriprise Financial Inc. Purchases Shares of 15,172 Akero Therapeutics, Inc. (NASDAQ:AKRO) - MarketBeat

Jun 08, 2025
pulisher
Jun 08, 2025

Akero Therapeutics, Inc. (NASDAQ:AKRO) VP Patrick Lamy Sells 4,000 Shares - MarketBeat

Jun 08, 2025
pulisher
Jun 08, 2025

Bronstein, Gewirtz & Grossman, LLC Encourages Akero Therapeutics, Inc. (AKRO) Shareholders to Inquire about Securities Investigation - ACCESS Newswire

Jun 08, 2025
pulisher
Jun 08, 2025

2025-06-08 | Bronstein, Gewirtz & Grossman, LLC Encourages Akero Therapeutics, Inc. (AKRO) Shareholders to Inquire about Securities Investigation | NDAQ:AKRO | Press Release - Stockhouse

Jun 08, 2025
pulisher
Jun 08, 2025

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Increases Stock Holdings in Akero Therapeutics, Inc. (NASDAQ:AKRO) - Defense World

Jun 08, 2025
pulisher
Jun 07, 2025

Bank of America Corp DE Sells 93,294 Shares of Akero Therapeutics, Inc. (NASDAQ:AKRO) - MarketBeat

Jun 07, 2025
pulisher
Jun 07, 2025

Day 7 of Gains Streak for Akero Therapeutics Stock with 20% Return (vs. 95% YTD) [6/6/2025] - Trefis

Jun 07, 2025
pulisher
Jun 06, 2025

Ionis Pharmaceuticals (NASDAQ:IONS) versus Akero Therapeutics (NASDAQ:AKRO) Financial Contrast - Defense World

Jun 06, 2025
pulisher
Jun 05, 2025

Bronstein, Gewirtz & Grossman, LLC Is Investigating Akero Therapeutics, Inc. (AKRO) And Encourages Shareholders to Connect - ACCESS Newswire

Jun 05, 2025
pulisher
Jun 05, 2025

Ameriprise Financial Inc. Makes New Investment in Akero Therapeutics, Inc. (NASDAQ:AKRO) - Defense World

Jun 05, 2025
pulisher
Jun 04, 2025

Akero Therapeutics Elects New Directors at Annual Meeting - TipRanks

Jun 04, 2025
pulisher
Jun 04, 2025

Two Sigma Advisers LP Acquires 27,200 Shares of Akero Therapeutics, Inc. (NASDAQ:AKRO) - MarketBeat

Jun 04, 2025
pulisher
Jun 04, 2025

Bank of America Corp DE Has $1.84 Million Stock Holdings in Akero Therapeutics, Inc. (NASDAQ:AKRO) - Defense World

Jun 04, 2025
pulisher
Jun 03, 2025

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Akero Therapeutics, Inc. (AKRO) And Encourages Shareholders to Reach Out - ACCESS Newswire

Jun 03, 2025
$20.39
price down icon 0.34%
$36.24
price down icon 0.27%
$23.15
price up icon 7.69%
$96.83
price down icon 0.40%
$108.13
price up icon 0.15%
biotechnology ONC
$247.47
price up icon 1.13%
자본화:     |  볼륨(24시간):